Gene expression profiling in a mouse model of retinal vein occlusion induced by laser treatment reveals a predominant inflammatory and tissue damage response

• Published in: PloS one Vol. 13; no. 3; p. e0191338
• Main Authors: Martin, Gottfried, Conrad, David, Cakir, Bertan, Schlunck, Günther, Agostini, Hansjürgen T
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 12-03-2018; Public Library of Science (PLoS)
• Subjects: Angiogenesis; Angiography; Animal models; Biology and Life Sciences; Blood vessels; Care and treatment; Cost effectiveness; Damage detection; Data interpretation; Diagnosis; Edema; Engineering and Technology; Epithelium; Eye; Eye (anatomy); Feasibility studies; Gene expression; Gene sequencing; Genes; Histopathology; Hypoxia; Inflammation; Kinases; Laboratory animals; Laser damage; Laser therapy; Lasers; Lectins; Medical imaging; Medicine and Health Sciences; Mice; Mutants; Occlusion; Pigs; Rabbits; Rats; Retina; Retinal diseases; Retinal pigment epithelium; Ribonucleic acid; RNA; RNA sequencing; Staining; Thrombosis; Vascular occlusion; Veins; Veins & arteries; United States > US; Germany
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0191338

Retinal vein occlusion (RVO) has been investigated in several laser-induced animal models using pigs, rabbits and rats. However, laser-induced RVO has been rarely reported in mice, despite the impressive number of available mutants, ease of handling and cost effectiveness. The aim of this study was to further assess the feasibility of a RVO mouse model for gene expression analysis and its possible use to investigate effects of hypoxia.
C57Bl/6J mice were injected with eosin Y for photo-sensitization. Subsequently, large retinal veins were laser-treated in one eye to induce vascular occlusion. Contralateral control eyes received non-occlusive retinal laser treatment sparing large vessels. The animals were followed for up to eight days and assessed by funduscopy, angiography, hypoxyprobe staining, histopathology and gene expression analysis by qPCR and RNA sequencing (RNAseq). Another group of mice was left untreated and studied at a single time point to determine baseline characteristics.
Laser-induced RVO persisted in half of the treated veins for three days, and in a third of the veins for the whole observation period of 8 days. Funduscopy revealed large areas of retinal swelling in all laser-treated eyes, irrespective of vascular targeting or occlusion status. Damage of the outer retina, retinal pigment epithelium (RPE), and even choroid and sclera at the laser site was observed in histological sections. Genes associated with inflammation or cell damage were highly up-regulated in all laser-treated eyes as detected by RNAseq and qPCR. Retinal hypoxia was observed by hypoxyprobe staining in all RVO eyes for up to 5 days with a maximal extension at days 2 and 3, but no significant RVO-dependent changes in gene expression were detected for angiogenesis- or hypoxia-related genes.
The laser-induced RVO mouse model is characterized by a predominant general inflammatory and tissue damage response, which may obscure distinct hypoxia- and angiogenesis-related effects. A non-occlusive laser treatment control is essential to allow for proper data interpretation and should be mandatory in animal studies of laser-induced RVO to dissect laser-induced tissue damage from vascular occlusion effects.